CDRT15P8

Across TCGA pan-cancer cohorts, CDRT15P8 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CDRT15P8’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where CDRT15P8 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CDRT15P8 is over-expressed in tumor, although a few such as LUSC and THCA show the opposite, repressed pattern.

BRCA, LUSC, and THCA are the cancer types where CDRT15P8 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CDRT15P8 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	+0.032	.009	4	view →
LUSC	Female	III,IV	−0.165	<.001	1	view →
THCA	Male	All	−0.040	.037	1	view →
LIHC	All	All	+0.038	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

CDRT15P8–BRCA

Open the BRCA breakdown →